ALACHUA, Fla., Feb. 2 /PRNewswire-FirstCall/ -- Tutogen Medical, Inc. , a leading manufacturer of sterile biological implant products made from human (allograft) and animal (xenograft) tissue, will report financial results for the first quarter ended December 31, 2005 on Thursday, February 9, 2006. The Company will discuss these results in a conference call scheduled for 4:15 p.m. ET, February 9, 2006.
Interested parties can access the call by dialing (877) 407-9205 or (201) 689-8054 or by accessing the web cast at http://www.tutogen.com/investor.asp. A replay of the call will be available at (877) 660-6853 or (201) 612-7415, account number 286 and access number 189201 for 7 days following the call, and the web cast can be accessed at http://www.tutogen.com/investor.asp for 30 days.
About Tutogen Medical, Inc.
Tutogen Medical, Inc. manufactures sterile biological implant products made from human (allograft) and animal (xenograft) tissue. Tutogen utilizes its Tutoplast Process(R) of tissue preservation and viral inactivation to manufacture and deliver sterile bio-implants used in spinal/trauma, urology, dental, ophthalmology, and general surgery procedures. The Company’s Tutoplast(R) products are sold and distributed worldwide by Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc., the Mentor Corporation, IOP, Inc. and through independent distributors and subsidiaries in the U.S. and Germany. For more information, visit the Company’s Web site at http://www.tutogen.com.
Contacts: George Lombardi, Chief Financial Officer Lytham Partners, LLC Tutogen Medical, Inc. Institutional: Joe Diaz 386-462-0402 Retail: Joe Dorame glombardi@tutogen.com 602-889-9700
Tutogen Medical, Inc.
CONTACT: George Lombardi, Chief Financial Officer of Tutogen Medical,Inc., +1-386-462-0402, glombardi@tutogen.com; or Institutional, Joe Diaz,or Retail, Joe Dorame, both of Lytham Partners, LLC, +1-602-889-9700, forTutogen Medical, Inc.
